Automatic Characterization of the Neonatal Hip Using Ultrasound Imaging
1 other identifier
observational
75
1 country
1
Brief Summary
Ultrasound imaging (US), a radiation-free imaging modality, is currently used in diagnosis of developmental dysplasia of the hip (DDH) in infants. The current protocol involves manually identifying specific measures that are prone to error, and may give rise to false positives. We aim to use 2-dimensional (2D) and 3-dimensional (3D) ultrasound imaging to create an automatic measurement procedure that we hope will reduce the errors in measurement and increase reliability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 26, 2016
CompletedFirst Posted
Study publicly available on registry
June 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedJune 13, 2016
June 1, 2016
2.5 years
May 26, 2016
June 7, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Alpha angles automatically extracted from 3D US images as a measure of dysplasia of the infant hip
Baseline
Alpha angles automatically extracted/measured from 2D US images as a measure of dysplasia of the infant hip
Baseline
Secondary Outcomes (4)
Beta angles automatically extracted from 3D US images as a measure of dysplasia of the infant hip
Baseline
Beta angles automatically extracted/measured from 2D US images as a measure of dysplasia of the infant hip
Baseline
Femoral head coverage automatically extracted from 3D US images as a measure of dysplasia of the infant hip
Baseline
Femoral head coverage automatically extracted/measured from 2D US images as a measure of dysplasia of the infant hip
Baseline
Study Arms (1)
Participants
Study participants will be 0 to 4 months of age and undergoing DDH screening. They will have the following scans: BASELINE - 1 3D US scanning session of right and left hip by Specialist 1, 1 3D US scanning session of right and left hip by Specialist 2, 1 2D US scanning session of right and left hip by Specialist 1, 1 2D US scanning session of right and left hip by Specialist 2. FOLLOW-UP (OPTIONAL) - 1 3D US scanning session of right and left hip by Specialist 1, 1 3D US scanning session of right and left hip by Specialist 2, 1 2D US scanning session of right and left hip by Specialist 1, 1 2D US scanning session of right and left hip by Specialist 2.
Interventions
3D ultrasound will be used by both clinicians to scan both the right and left hips of the infant.
2D ultrasound will be used by both clinicians to scan both the right and left hips of the infant.
Eligibility Criteria
Infants that have been referred to the Orthopaedic Clinic at our institution for suspected or diagnosed Developmental Dysplasia of the Hip (DDH).
You may qualify if:
- Children with suspected DDH at our institution
- Ages 0 to 4 months of age
You may not qualify if:
- US not performed at our institution
- No diagnosis of DDH or not suspected of having DDH
- Other congenital hip abnormalities or genetic syndromes
- Patient/family does not live in the Lower Mainland
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3V4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kishore Mulpuri, MBBS, MS(Ortho), MHSc
Provincial Health Services Authority British Columbia
- PRINCIPAL INVESTIGATOR
Antony Hodgson, BASc, MASc, PhD
University of British Columbia
- PRINCIPAL INVESTIGATOR
Anthony Cooper, BSc, MBChB, FRCS
Provincial Health Services Authority British Columbia
- PRINCIPAL INVESTIGATOR
Rafeef Abugharbieh, BSc, MSc, PhD
University of British Columbia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Orthopaedic Surgeon
Study Record Dates
First Submitted
May 26, 2016
First Posted
June 13, 2016
Study Start
December 1, 2014
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
June 13, 2016
Record last verified: 2016-06
Data Sharing
- IPD Sharing
- Will not share